Advances in Yeast Probiotic Production and Formulation for Preventative Health
Microorganisms · 04.11.2024 · 12 (11) · 2233
DOI: 10.3390/microorganisms12112233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 04.11.2024. Verfasst von Ghaneshree Moonsamy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Council for Scientific and Industrial Research (CSIR) Future Production Chemicals, Meiring Naude Drive, Pretoria 0081, South Africa. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Innovation South Africa, Department of Science and Innovation, CSIR’s Special Initiatives Parliamentary Grant Fund.
Abstract (Originalsprache)
The use of probiotics has been gaining popularity in terms of inclusion into human diets over recent years. Based on properties exerted by these organisms, several benefits have been elucidated and conferred to the host. Bacteria have been more commonly used in probiotic preparations compared to yeast candidates; however, yeast exhibit several beneficial properties, such as the prevention and treatment of diarrhea, the production of antimicrobial agents, the prevention of pathogen adherence to intestinal sites, the maintenance of microbial balance, the modulation of the immune system, antibiotic resistance, amongst others. Saccharomyces boulardii is by far the most studied strain; however, the potential for the use of other yeast candidates, such as Kluyveromyces lactis and Debaryomyces hansenii, amongst others, have also been evaluated in this review. Furthermore, a special focus has been made regarding the production considerations for yeast-based probiotics and their formulation into different delivery formats. When drafting this review, evidence suggests that the use of yeasts, both wild-type and genetically modified candidates, can extend beyond gut health to support skin, the respiratory system, and overall immune health. Hence, this review explores the potential of yeast probiotics as a safe, effective strategy for preventative health in humans, highlighting their mechanisms of action, clinical applications, and production considerations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Council for Scientific and Industrial Research (CSIR) Future Production Chemicals, Meiring Naude Drive, Pretoria 0081, South Africa.
Förderung
- Department of Science and Innovation South Africa
- Department of Science and Innovation
- CSIR’s Special Initiatives Parliamentary Grant Fund
Zitieren
APA
Moonsamy, G., Roets-Dlamini, Y., Langa, C. N., & Ramchuran, S. O. (2024). Advances in Yeast Probiotic Production and Formulation for Preventative Health. Microorganisms, 12(11), 2233. https://doi.org/10.3390/microorganisms12112233
Vancouver
Moonsamy G, Roets-Dlamini Y, Langa CN, Ramchuran SO. Advances in Yeast Probiotic Production and Formulation for Preventative Health. Microorganisms. 2024;12(11):2233. doi:10.3390/microorganisms12112233
BibTeX
@article{Moonsamy2024,
author = {Moonsamy, Ghaneshree and Roets-Dlamini, Yrielle and Langa, Cebeni Nkosihawukile and Ramchuran, Santosh Omrajah},
title = {Advances in Yeast Probiotic Production and Formulation for Preventative Health},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {11},
pages = {2233},
doi = {10.3390/microorganisms12112233}
}
EUVIMED